Linda J.W. Bosch - Concepedia

Author

Linda J.W. Bosch

Also Known As

L BOSCH, L Bosch, L. Bosch, L. J. W. Bosch, L.J.W. Bosch, Linda Bosch, Linda J W Bosch, Linda J. Bosch, Linda J. W. Bosch, Linda J.W. Bosch

147

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute Amsterdam UMC Location Vrije Universiteit Amsterdam University Medical Center Utrecht Amsterdam University Medical Centers

About

Linda J.W. Bosch is an author at The Netherlands Cancer Institute specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	841
2	Health Sciences	3	3	105
3	Public Health	2	2	61
4	Engineering	1	1	30
5	Natural Sciences	1	1	14

Linda J.W. Bosch

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial Elisa A. Rozeman, Alexander M. Menzies, Alexander C. J. van Akkooi, The Lancet Oncology OncologyMedicineMelanomaImmune Checkpoint InhibitorDermatology	2019	498
Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population Linda J.W. Bosch, Veerle Melotte, Sandra Mongera, The American Journal of Gastroenterology	2019	90
Consensus molecular subtype classification of colorectal adenomas Malgorzata A. Komor, Linda J.W. Bosch, Gergana Bounova, The Journal of Pathology	2018	84
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma Irene L. M. Reijers, Disha Rao, Judith M. Versluis, The Journal of Experimental Medicine Cancer ImmunosurveillanceMedicineDonimi TrialImmunologyTumor Immunity	2023	70
Genomic landscape of metastatic colorectal cancer Josien Haan, Mariëtte Labots, Christian Rausch, Nature Communications PathologyTumor BiologyGastrointestinal OncologyTumor HeterogeneityCancer Cell Biology	2014	67
Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer Annika Jacobsen, Linda J.W. Bosch, Sanne R. Martens‐de Kemp, Scientific Reports	2018	60
Prognostic value of <i>BRAF</i> and <i>KRAS</i> mutation status in stage II and III microsatellite instable colon cancers Erienne M.V. de Cuba, Daniëlle A.M. Heideman, Nicole C.T. van Grieken, International Journal of Cancer	2015	59
Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening Linda J.W. Bosch, Meike de Wit, Thang V. Pham, Annals of Internal Medicine	2017	56
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21 Sarah Derks, Linda J.W. Bosch, Hanneke E.C. Niessen, Carcinogenesis	2009	55
DNA Methylation of Phosphatase and Actin Regulator 3 Detects Colorectal Cancer in Stool and Complements FIT Linda J.W. Bosch, Frank A. Oort, Maarten Neerincx, Cancer Prevention Research	2011	53

Page 1